跳至主要内容
临床试验/IRCT2017050833875N1
IRCT2017050833875N1已完成3 期

Effect of intravitreal injection of Bevacizumab and subtenon injection of Triamcinolone and topical diclofenac eye drop in preventing the incidence of diabetic macular edema after phaco with intraocular lens implementing

Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences0 个研究点目标入组 45 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Inclusion Criteria: Diabetic patients with cataract and without diabetic macular edema; Nonproliferation diabetic retinopathy.

排除标准

  • Glaucoma; Eye trauma; Laser therapy 12 months prior to cataract surgery; Any history of eye surgery 6 months ago.

研究者

发起方
Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences

相似试验